Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • In Brief
  • Published:

GENE THERAPY

Long-term follow-up of hemophilia gene therapy in dogs

Lab Animal volume 50, page 14 (2021)Cite this article

Nguyen, G.N., Everett, J.K. et al. Nat Biotechnol. https://doi.org/10.1038/s41587-020-0741-7 (2020)

Clinical trials evaluating adeno-associated viral (AAV) vector-mediated delivery of factor VIII (FVIII) show promise for the treatment of haemophilia A (HA), but the long-term effects of AAV gene therapy remain unknown.

This is a preview of subscription content, access via your institution

Access options

Author information

Authors and Affiliations

  1. Lab Animal http://www.nature.com/laban/

    Alexandra Le Bras

Authors
  1. Alexandra Le Bras
    View author publications

    Search author on:PubMed Google Scholar

Corresponding author

Correspondence to Alexandra Le Bras.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Le Bras, A. Long-term follow-up of hemophilia gene therapy in dogs. Lab Anim 50, 14 (2021). https://doi.org/10.1038/s41684-020-00700-z

Download citation

  • Published:

  • Version of record:

  • Issue date:

  • DOI: https://doi.org/10.1038/s41684-020-00700-z

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing